Daybue and Levocarnitine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Daybue (trofinetide) and Levocarnitine (levocarnitine). Common drug interactions include diarrhoea among females and diarrhoea among males.

The phase IV clinical study analyzes what interactions people have when they take Daybue and Levocarnitine. It is created by eHealthMe based on reports of 38 people who take the same drugs from the FDA, and is updated regularly.

What is Daybue?

Daybue has active ingredients of trofinetide. eHealthMe is studying from 1,959 Daybue users. Check the latest studies of Daybue.

What is Levocarnitine?

Levocarnitine has active ingredients of levocarnitine. It is often used in mitochondrial myopathy. eHealthMe is studying from 3,332 Levocarnitine users. Check the latest studies of Levocarnitine.

On Aug, 02, 2026

38 people who take Daybue and Levocarnitine together, and have interactions are studied.

Daybue and Levocarnitine drug interactions.

What are the common drug interactions of Daybue and Levocarnitine, by gender? *:

female:

Diarrhoea
Vomiting
Seizure (abnormal excessive or synchronous neuronal activity in the brain)
Hypersomnia (excessive daytime sleepiness (eds))
Dehydration (dryness resulting from the removal of water)
Hypophagia (reduced food intake)
Constipation
Nausea (feeling of having an urge to vomit)
Retching (strong involuntary effort to vomit)
Secretion discharge

male:

Diarrhoea
Rash
Pneumonia
Fungal infection
Purpura (purplish discoloration of the skin)
Wound
Drug ineffective
Respiratory tract infection
Somnolence (a state of near-sleep, a strong desire for sleep)
Vomiting

What are the common drug interactions of Daybue and Levocarnitine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

Diarrhoea
Vomiting
Dehydration (dryness resulting from the removal of water)
Influenza
Hypophagia (reduced food intake)
Drug ineffective
Aggression
Cough
Fatigue (feeling of tiredness)
Pyrexia (fever)

10-19:

Diarrhoea
Hypersomnia (excessive daytime sleepiness (eds))
Seizure (abnormal excessive or synchronous neuronal activity in the brain)
Vomiting
Abdominal discomfort
Nausea (feeling of having an urge to vomit)
Adverse drug reaction
Hypophagia (reduced food intake)
Pneumonia
Vomiting projectile

20-29:

Constipation
Abnormal behaviour
Blood potassium decreased
Dehydration (dryness resulting from the removal of water)
Gastrointestinal disorder (functional problems of gastrointestinal tract)
Hypophagia (reduced food intake)
Weight bearing difficulty (difficulty due to weight of thigh fat deposition)
Sleep terror (felling of terror in sleep)
Abnormal faeces (abnormal stool)
Dermatitis diaper (diaper rash is a common form of inflamed skin)

30-39:

Diarrhoea
Rash
Fungal infection
Pneumonia
Purpura (purplish discoloration of the skin)
Wound

40-49:

n/a

50-59:

n/a

60+:

n/a

What are the existing conditions these people have? *

Hypersensitivity: 8 people, 21.05%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 5 people, 13.16%
Constipation: 4 people, 10.53%
Pain: 3 people, 7.89%
Fever: 3 people, 7.89%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 3 people, 7.89%
Seasonal Allergy (allergic condition due to certain season): 2 people, 5.26%
Nausea And Vomiting: 2 people, 5.26%
Nausea (feeling of having an urge to vomit): 2 people, 5.26%
Menstrual Disorder (disease of menstrual cycle): 2 people, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Daybue and Levocarnitine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously